Tail Suspension Test
Objective: Measure depression-like behavior by assessing immobility time when a mouse is suspended by the tail
This is a Tail Suspension Test protocol using mouse as the model organism. The procedure involves 5 procedural steps, 1 equipment items, 4 materials. Extracted from a 2022 paper published in Journal of Neuroinflammation.
Model and subjects
mouse • Not specified • unknown • Not specified • Not specified
Study window
~1 hours hands-on
Core workflow
Establish CSDS depression model • Administer inhibitors • Administer EDA treatment
Primary readouts
- Immobility time during tail suspension test
- Depression-like behavior assessment
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Establish CSDS depression model
Perform chronic social defeat stress (CSDS) to induce depression-like phenotype in mice
Note: This is the baseline condition before behavioral testing
View evidence from paper
“A chronic social defeat stress (CSDS) depression model was performed to explore whether EDA could produce antidepressant effects”
Administer inhibitors
Inject EX527 (Sirt1 inhibitor) and ML385 (Nrf2 inhibitor) intraperitoneally 30 minutes before EDA injection
Note: Inhibitors administered daily
View evidence from paper
“EX527, a Sirt1 inhibitor and ML385, a Nrf2 inhibitor were injected intraperitoneally 30 min before EDA injection daily”
Administer EDA treatment
Inject EDA daily following inhibitor administration
Note: Administered after 30-minute interval from inhibitor injection
View evidence from paper
“EX527, a Sirt1 inhibitor and ML385, a Nrf2 inhibitor were injected intraperitoneally 30 min before EDA injection daily”
Perform tail suspension test
Suspend mouse by the tail and measure immobility time as an indicator of depression-like behavior
Note: Part of comprehensive behavioral testing battery
View evidence from paper
“Behaviors tests were carried out to examine depressive, anxiety-like and cognitive behaviors including social interaction (SI) test, sucrose preference test (SPT), open field test (OFT), elevated plus maze (EPM), novel object recognition (NOR), tail suspension test (TST) and forced swim test (FST)”
Perform AAV-mediated Gpx4 knockdown
Infuse adeno-associated virus vector containing miRNAi (Gpx4)–EGFP to knockdown Gpx4 expression in CSDS mice treated with EDA
Note: Separate experimental group to determine Gpx4 effects
View evidence from paper
“Knockdown experiments were performed to determine the effects of Gpx4 on CSDS mice with EDA treatment by an adeno-associated virus (AAV) vector containing miRNAi (Gpx4)–EGFP infusion”